Download PDF
Journal of Pediatric Neurology 2015; 13(01): 042-045
DOI: 10.1055/s-0035-1555153
Review Article
Georg Thieme Verlag KG Stuttgart · New York

Pseudotumor Cerebri Syndrome and Renal Diseases in the Pediatric Population

Roberto Chimenz
1   Department of Pediatrics, University of Messina, Messina, Italy
,
Valeria Dipasquale
1   Department of Pediatrics, University of Messina, Messina, Italy
,
Dominique De Vivo
1   Department of Pediatrics, University of Messina, Messina, Italy
,
Federica Sancetta
1   Department of Pediatrics, University of Messina, Messina, Italy
,
Anna Claudia Romeo
1   Department of Pediatrics, University of Messina, Messina, Italy
,
Valeria Chirico
1   Department of Pediatrics, University of Messina, Messina, Italy
,
Antonio Lacquaniti
2   Department of Internal Medicine, Mediterranean Institute for Transplantation and Advanced Specialized Therapies, University of Pittsburgh Medical Center, Palermo, Italy
› Author Affiliations
Further Information

Publication History

27 October 2014

06 January 2015

Publication Date:
13 July 2015 (online)

Also available at
    Permissions and Reprints

Abstract

Pseudotumor cerebri syndrome (PTCS) is defined as a syndrome of markedly elevated intracranial pressure, with no evidence of intracranial mass, inflammation or obstruction on brain imaging. Headache, visual disturbances (e.g., diplopia, visual loss), and papilledema are the most common presenting features. The mechanism(s) underlying PTCS is still unknown. Numerous medical illnesses and medications have been associated with the risk of PTCS, and a range of renal disorders (e.g., renal transplantation, nephrotic syndrome, inherited tubulopathies, acute or chronic kidney insufficiency) can predispose to developing this raised intracranial pressure syndrome. Fluid and electrolyte balance in renal epithelial cells are regulated by a complex interaction of metabolic and/or hormonal factors. In this context, we also discuss recent studies that suggest that renal epithelial cells share many of the same features as the choroid plexus epithelial cells, which are involved in the regulation of cerebrospinal fluid dynamics.

Keywords

idiopathic intracranial hypertension - pseudotumor cerebri - children - nephrotic syndrome - Gitelman syndrome - Bartter syndrome - renal failure
 

  • References

  • 1 Friedman DI, Liu GT, Digre KB. Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children. Neurology 2013; 81 (13) 1159-1165
    CrossrefPubMedGoogle Scholar
  • 2 Rangwala LM, Liu GT. Pediatric idiopathic intracranial hypertension. Surv Ophthalmol 2007; 52 (6) 597-617
    CrossrefPubMedGoogle Scholar
  • 3 Soiberman U, Stolovitch C, Balcer LJ, Regenbogen M, Constantini S, Kesler A. Idiopathic intracranial hypertension in children: visual outcome and risk of recurrence. Childs Nerv Syst 2011; 27 (11) 1913-1918
    CrossrefPubMedGoogle Scholar
  • 4 Salpietro V, Polizzi A, Bertè LF , et al. Idiopathic intracranial hypertension: a unifying neuroendocrine hypothesis through the adrenal-brain axis. Neuroendocrinol Lett 2012; 33 (6) 569-573
    PubMedGoogle Scholar
  • 5 Salpietro V, Chimenz R, Arrigo T, Ruggieri M. Pediatric idiopathic intracranial hypertension and extreme childhood obesity: a role for weight gain. J Pediatr 2013; 162 (5) 1084
    PubMedGoogle Scholar
  • 6 Chang D, Nagamoto G, Smith WE. Benign intracranial hypertension and chronic renal failure. Cleve Clin J Med 1992; 59 (4) 419-422
    CrossrefPubMedGoogle Scholar
  • 7 Dobrowolsky W. Amourosis uraemia in folge von schnervenoedem. Klin Monatsbl Augenheilkd 1881; 19: 121-123 (in German)
    PubMedGoogle Scholar
  • 8 Barnett M, Sinha MD, Morrison D, Lim M. Intracranial hypertension presenting with severe visual failure, without concurrent headache, in a child with nephrotic syndrome. BMC Pediatr 2013; 13: 167
    CrossrefPubMedGoogle Scholar
  • 9 Francis PJ, Haywood S, Rigden S, Calver DM, Clark G. Benign intracranial hypertension in children following renal transplantation. Pediatr Nephrol 2003; 18 (12) 1265-1269
    CrossrefPubMedGoogle Scholar
  • 10 Chamberlain CE, Fitzgibbon E, Wassermann EM , et al. Idiopathic intracranial hypertension following kidney transplantation: a case report and review of the literature. Pediatr Transplant 2005; 9 (4) 545-550
    CrossrefPubMedGoogle Scholar
  • 11 Tugal O, Jacobson R, Berezin S , et al. Recurrent benign intracranial hypertension due to iron deficiency anemia. Case report and review of the literature. Am J Pediatr Hematol Oncol 1994; 16 (3) 266-270
    CrossrefPubMedGoogle Scholar
  • 12 Perna AF, Ingrosso D, Molino D , et al. Hyperhomocysteinemia and protein damage in chronic renal failure and kidney transplant pediatric patients—Italian initiative on uremic hyperhomocysteinemia (IIUH). J Nephrol 2003; 16 (4) 516-521
    PubMedGoogle Scholar
  • 13 Biousse V, Ameri A, Bousser MG. Isolated intracranial hypertension as the only sign of cerebral venous thrombosis. Neurology 1999; 53 (7) 1537-1542
    CrossrefPubMedGoogle Scholar
  • 14 Pasini A, Aceto G, Ammenti A , et al; NefroKid Study Group. Best practice guidelines for idiopathic nephrotic syndrome: recommendations versus reality. Pediatr Nephrol 2015; 30 (1) 91-101
    CrossrefPubMedGoogle Scholar
  • 15 Fede C, Conti G, Chimenz R, Ricca M. N-acetyl-beta-D-glucosaminidase and beta2-microglobulin: prognostic markers in idiopathic nephrotic syndrome. J Nephrol 1999; 12 (1) 51-55
    PubMedGoogle Scholar
  • 16 Ammenti A, Müller-Wiefel DE, Schärer K, Vecsei P. Mineralocorticoids in the nephrotic syndrome of children. Clin Nephrol 1980; 14 (5) 238-245
    PubMedGoogle Scholar
  • 17 Yang GF, Schoepf UJ, Zhu H, Lu GM, Gray III JC, Zhang LJ. Thromboembolic complications in nephrotic syndrome: imaging spectrum. Acta Radiol 2012; 53 (10) 1186-1194
    CrossrefPubMedGoogle Scholar
  • 18 Salpietro V, Ruggieri M. Pseudotumor cerebri pathophysiology: the likely role of aldosterone. Headache 2014; 54 (7) 1229
    CrossrefPubMedGoogle Scholar
  • 19 Khan MU, Khalid H, Salpietro V, Weber KT. Idiopathic intracranial hypertension associated with either primary or secondary aldosteronism. Am J Med Sci 2013; 346 (3) 194-198
    CrossrefPubMedGoogle Scholar
  • 20 Vidal E, Edefonti A, Murer L , et al; Italian Registry of Paediatric Chronic Dialysis. Peritoneal dialysis in infants: the experience of the Italian Registry of Paediatric Chronic Dialysis. Nephrol Dial Transplant 2012; 27 (1) 388-395
    CrossrefPubMedGoogle Scholar
  • 21 Ghosh S, Sarkar K, Mukhopadhyay S, Bhaduri G. Idiopathic intracranial hypertension in a child after hemodialysis. Pediatr Neurol 2008; 39 (4) 272-275
    CrossrefPubMedGoogle Scholar
  • 22 Belson A, Alcorn DM, Yorgin PD, Fisher PG, Sarwal M. Visual loss caused by pseudotumor cerebri in an infant on peritoneal dialysis. Pediatr Nephrol 2001; 16 (3) 216-218
    CrossrefPubMedGoogle Scholar
  • 23 Korzets A, Gafter U, Floru S, Chagnac A, Zevin D. Deteriorating renal function with acetazolamide in a renal transplant patient with pseudotumor cerebri. Am J Kidney Dis 1993; 21 (3) 322-4
    CrossrefPubMedGoogle Scholar
  • 24 Salpietro V, Ruggieri M, Sancetta F , et al. New insights on the relationship between pseudotumor cerebri and secondary hyperaldosteronism in children. J Hypertens 2012; 30 (3) 629-630
    PubMedGoogle Scholar
  • 25 Konomi H, Imai M, Nihei K, Kamoshita S, Tada H. Indomethacin causing pseudotumor cerebri in Bartter's syndrome. N Engl J Med 1978; 298 (15) 855
    PubMedGoogle Scholar
  • 26 Larizza D, Colombo A, Lorini R, Severi F. Ketoprofen causing pseudotumor cerebri in Bartter's syndrome. N Engl J Med 1979; 300 (14) 796
    PubMedGoogle Scholar
  • 27 Godefroid N, Riveira-Munoz E, Saint-Martin C, Nassogne MC, Dahan K, Devuyst O. A novel splicing mutation in SLC12A3 associated with Gitelman syndrome and idiopathic intracranial hypertension. Am J Kidney Dis 2006; 48 (5) e73-e79
    CrossrefPubMedGoogle Scholar
  • 28 Seyberth HW, Schlingmann KP. Bartter- and Gitelman-like syndromes: salt-losing tubulopathies with loop or DCT defects. Pediatr Nephrol 2011; 26 (10) 1789-1802
    CrossrefPubMedGoogle Scholar
  • 29 Salpietro V, Polizzi A, Di Rosa G , et al. Adrenal disorders and the paediatric brain: pathophysiological considerations and clinical implications. Int J Endocrinol 2014; 2014: 282489
    PubMedGoogle Scholar
  • 30 Andrews LE, Liu GT, Ko MW. Idiopathic intracranial hypertension and obesity. Horm Res Paediatr 2014; 81 (4) 217-225
    CrossrefPubMedGoogle Scholar
  • 31 Salpietro V, Mankad K, Kinali M , et al. Pediatric idiopathic intracranial hypertension and the underlying endocrine-metabolic dysfunction: a pilot study. J Pediatr Endocrinol Metab 2014; 27 (1–2) 107-115
    PubMedGoogle Scholar
  • 32 Chirico V, Lacquaniti A, Salpietro V , et al. High-mobility group box 1 (HMGB1) in childhood: from bench to bedside. Eur J Pediatr 2014; 173 (9) 1123-1136
    CrossrefPubMedGoogle Scholar
  • 33 Chirico V, Cannavò S, Lacquaniti A , et al. Prolactin in obese children: a bridge between inflammation and metabolic-endocrine dysfunction. Clin Endocrinol (Oxf) 2013; 79 (4) 537-544
    CrossrefPubMedGoogle Scholar
  • 34 Chirico V, Ferraù V, Loddo I , et al. LMNA gene mutation as a model of cardiometabolic dysfunction: from genetic analysis to treatment response. Diabetes Metab 2014; 40 (3) 224-228
    CrossrefPubMedGoogle Scholar
  • 35 Arrigo T, Chirico V, Salpietro V , et al. High-mobility group protein B1: a new biomarker of metabolic syndrome in obese children. Eur J Endocrinol 2013; 168 (4) 631-638
    CrossrefPubMedGoogle Scholar
  • 36 Sheldon CA, Kwon YJ, Liu GT, McCormack SE. An integrated mechanism of pediatric pseudotumor cerebri syndrome: evidence of bioenergetic and hormonal regulation of cerebrospinal fluid dynamics. Pediatr Res 2015; 77 (2) 282-289
    CrossrefPubMedGoogle Scholar
  • 37 Boedtkjer E, Praetorius J, Füchtbauer EM, Aalkjaer C. Antibody-independent localization of the electroneutral Na+-HCO3- cotransporter NBCn1 (slc4a7) in mice. Am J Physiol Cell Physiol 2008; 294 (2) C591-C603
    CrossrefPubMedGoogle Scholar
  • 38 Keep RF, Smith DE. Choroid plexus transport: gene deletion studies. Fluids Barriers CNS 2011; 8 (1) 26
    CrossrefPubMedGoogle Scholar
  • 39 Johanson CE, Duncan III JA, Klinge PM, Brinker T, Stopa EG, Silverberg GD. Multiplicity of cerebrospinal fluid functions: new challenges in health and disease. Cerebrospinal Fluid Res 2008; 5: 10
    CrossrefPubMedGoogle Scholar